Search results
Results From The WOW.Com Content Network
In July 2020, Pfizer and BioNTech announced that two of the partners' four mRNA vaccine candidates had won fast track designation from the FDA. [125] The company began Phase II-III testing on 30,000 people in the last week of July 2020 and was slated to be paid $1.95 billion for 100 million doses of the vaccine by the US government. [ 126 ]
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials , logistics, and manufacturing.
BioNTech was founded in 2008 based on research by Uğur Şahin, Özlem Türeci, [8] and Christoph Huber, [9] with a seed investment of €180 million [10] from MIG Capital, a Munich-based venture capital firm, the family office of Andreas and Thomas Strüngmann, and the present chairman of the supervisory board, Helmut Jeggle.
Download as PDF; Printable version; From Wikipedia, the free encyclopedia. Redirect page. Redirect to: Pfizer–BioNTech COVID-19 vaccine; Retrieved from " ...
Kathrin U. Jansen (born 1958) is the former [1] Head of Vaccine Research and Development at Pfizer.She previously led the development of the HPV vaccine and newer versions of the pneumococcal conjugate vaccine (), and is working with BioNTech to create a COVID-19 vaccine using mRNA (Pfizer–BioNTech COVID-19 vaccine) that was approved for Emergency Use Authorization in the United States on ...
Pfizergate refers to a scandal involving European Commission President Ursula von der Leyen and the American pharmaceutical company Pfizer over the procurement of COVID-19 vaccines. The controversy centers on the lack of transparency in the communication and negotiation processes for purchasing a significant number of vaccine doses during the ...
On 21 December 2020, the CHMP recommended granting a conditional marketing authorization for the Pfizer-BioNTech COVID‑19 vaccine, Comirnaty (active ingredient tozinameran), developed by BioNTech and Pfizer. [144] [145] [22] The recommendation was accepted by the European Commission the same day. [144] [146] [147] [148]
Drew Weissman (born September 7, 1959) is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).